Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites.
Marco Di PascoliSilvano FasolatoSalvatore PianoMassimo BolognesiPaolo AngeliPublished in: Liver international : official journal of the International Association for the Study of the Liver (2018)
In patients with cirrhosis and refractory ascites, long-term treatment with albumin improves survival and reduces the probability of emergent hospitalizations.